peri implant disease

The effects of photo dynamic therapy and nonsurgical mechanical debriment on pocket depth and bleeding of probing in peri-implant disease

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180913041033N1

Enrollment

Registered

2019-01-07

Start date

2017-04-25

Completion date

Unknown

Last updated

2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peri-implantitis. Gingivitis and periodontal diseases

Interventions

Intervention 1: control group:: The initial treatment protocol in both groups includes health education and removal of the mass and plaque using the ultrasonic curing apparatus (250.EMSElectroMedical

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria bleeding of probing(bop) Depth of probing greater than or equal to four millimeters Under the implant's function for 1 year or more Failure of recession soft tissue with or without a minimum bone recession less than or equal to 2 mm

Exclusion criteria

Exclusion criteria: Exclusion criteria Pregnancy and lactation Addicted to drugs and alcohol Uncontrolled diabetes and disabling systemic disease smokers

Design outcomes

Primary

Measure	Time frame
Bleeding on probing. Timepoint: Two weeks after mechanical and photodynamic therapy and at the end of the follow-up phase. Method of measurement: Bleeding on probing:The probe is carefully inserted into the pocket and slowly moves to the side of the implant and records bleeding if observed.	—

Secondary

Measure	Time frame
Suppuration. Timepoint: Baseline two weeks later, three months later. Method of measurement: The presence of (1) or loss of (0) by itself, after a probe or gingival pressure around the implant, Recorded with finger.;Pain on Probing(POP). Timepoint: Baseline two weeks later, three months later. Method of measurement: How to measure pain using the Visual Analogue Scale (VAS) method: A ruler that is about ten centimeters in length is provided to the patient, and it is explained that if the pain is greatest in the entire length of the ruler and the lowest in the left end In this case, mark the amount of pain on the ruler. The distance from the marked point to the left is measured and reported in cm.;Probing Depth (PD). Timepoint: Baseline two weeks later, three months later. Method of measurement: Depth of probe: In six points around the implants (Mesobuccal, Mid Buccal, Disto Buccal, Meso Lingual, Disto Lingual and Mid Lingual), the margin of the mucosa of the implant was measured to the depth of the gingival area with the probe and the deepest probe region was recorded as the probing depth.	—

Measure

Time frame

Suppuration. Timepoint: Baseline two weeks later, three months later. Method of measurement: The presence of (1) or loss of (0) by itself, after a probe or gingival pressure around the implant, Recorded with finger.;Pain on Probing(POP). Timepoint: Baseline two weeks later, three months later. Method of measurement: How to measure pain using the Visual Analogue Scale (VAS) method: A ruler that is about ten centimeters in length is provided to the patient, and it is explained that if the pain is greatest in the entire length of the ruler and the lowest in the left end In this case, mark the amount of pain on the ruler. The distance from the marked point to the left is measured and reported in cm.;Probing Depth (PD). Timepoint: Baseline two weeks later, three months later. Method of measurement: Depth of probe: In six points around the implants (Mesobuccal, Mid Buccal, Disto Buccal, Meso Lingual, Disto Lingual and Mid Lingual), the margin of the mucosa of the implant was measured to the depth of the gingival area with the probe and the deepest probe region was recorded as the probing depth.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDavood fathollahzadeh

Tabriz University of Medical Sciences

fathollahzadeh@tazmed.ac.ir+98 41 3331 9677

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026